Article
LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans
medRxiv · 2021 · Jaewon Song, author Ryan D. Chow, author Mario Pena-Hernandez, author Li Zhang, author Skylar A. Loeb, author Eui-Young So, author Olin D. Liang, author Craig B. Wilen, author Sanghyun Lee, author
Key facts
| Title | LRRC15 is an inhibitory receptor blocking SARS-CoV-2 spike-mediated entry in trans |
|---|---|
| First author | Jaewon Song, author Ryan D. Chow, author Mario Pena-Hernandez, author Li Zhang, author Skylar A. Loeb, author Eui-Young So, author Olin D. Liang, author Craig B. Wilen, author Sanghyun Lee, author |
| Journal | medRxiv |
| Published | Nov 27, 2021 |
| DOI | 10.1101/2021.11.23.469714 |
| Devices mentioned | K073490, K202641, K231013, K873891, K905086 |
| Product codes mentioned | CFN, JJH, MVU, PFT, KIZ, QBD |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1